Synaptogenix Announces Material Agreement, Officer Changes
Ticker: TAOX · Form: 8-K · Filed: Jun 9, 2025 · CIK: 1571934
| Field | Detail |
|---|---|
| Company | Synaptogenix, Inc. (TAOX) |
| Form Type | 8-K |
| Filed Date | Jun 9, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, officer-changes, director-changes, equity-securities
TL;DR
Synaptogenix inked a big deal & shuffled execs. Big changes coming.
AI Summary
Synaptogenix, Inc. announced on June 4, 2025, the entry into a material definitive agreement. The company also reported on the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. Additionally, the filing includes information on unregistered sales of equity securities and a Regulation FD disclosure.
Why It Matters
This 8-K filing indicates significant corporate actions, including a new material agreement and changes in leadership, which could impact the company's strategic direction and operational stability.
Risk Assessment
Risk Level: medium — The filing details material definitive agreements and changes in officers/directors, which can introduce uncertainty and potential risks related to execution and governance.
Key Players & Entities
- Synaptogenix, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- June 4, 2025 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement entered into by Synaptogenix, Inc.?
The filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the provided text.
What specific changes occurred regarding directors or officers?
The filing reports on the departure of directors or certain officers, the election of directors, and the appointment of certain officers, along with compensatory arrangements.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on June 4, 2025.
What is Synaptogenix, Inc.'s former company name?
Synaptogenix, Inc.'s former company name was NEUROTROPE BIOSCIENCE, INC.
What is the SIC code for Synaptogenix, Inc.?
The Standard Industrial Classification (SIC) code for Synaptogenix, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 9, 2025 regarding Synaptogenix, Inc. (TAOX).